The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

AIM WINNERS & LOSERS: Synairgen sinks 18% after US Covid study halted

Thu, 17th Mar 2022 11:21

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Frontier IP Group PLC, up 11% at 87.80 pence, 12-month range 67.00p-130.70p. The intellectual property specialist says pretax profit rises in the first half, and it is confident in its outlook. For the six months that ended December 31, pretax profit more than triples to GBP10.3 million from GBP3.0 million. Says portfolio companies are seeing continued momentum. They are reaching important inflection points and making significant commercial, technical and industry progress. Frontier expects this progress "to be reflected by strong positive news flow in the months to come".

----------

Fevertree Drinks PLC, up 4.5% at 1,853.50p, 12-month range 1,456.09-2,871.00p. Bank of America raises the tonic water maker to 'neutral' from 'underperform'. Fevertree on Wednesday reported a strong set of annual results, with on- and off-trade both performing well.

----------

AIM - LOSERS

----------

Synairgen PLC, down 18% at 21.42p, 12-month range 10.00p-223.80p. The drug discovery company says US National Institute of Allergy & Infectious Diseases has stopped all patient recruitment in the phase 2/3 trial evaluating its inhalable drug SNG001 in patients with mild to moderate Covid-19.

----------

Autins Group PLC, down 13% at 17.00p, 12-month range 17.00p-26.83p. The supplier of acoustic and thermal management technology for the automotive industry says sales volumes in first half of financial 2022 remain similar to second half of financial 2021 due to semiconductor shortages. Says the industry had previously forecast an improvement in semiconductor supply in the second half of calendar year 2022, but the war in Ukraine adds to the overall uncertainty and timing of the recovery. Will release results for the six months ending March 31 in June.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Related Shares

More News
9 May 2024 15:51

UK dividends calendar - next 7 days

30 Apr 2024 14:21

Deutsche Bank starts coverage of Fevetree, Britvic at 'buy'

(Sharecast News) - Deutsche Bank initiated coverage of drinks companies Fevertree and Britvic on Tuesday with 'buy' rating.

30 Apr 2024 09:46

LONDON BROKER RATINGS: Deutsche says buy Barr, Britvic and Fevertree

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

27 Mar 2024 09:40

LONDON BROKER RATINGS: Sainsbury's, Petershill Partners upped to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

26 Mar 2024 11:38

Fevertree earnings fall in mixed year for company

(Sharecast News) - Fevertree Drinks reported a mixed set of results for 2023 on Tuesday, with UK revenue down 1% to £114.8m, while US revenue jum...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.